Zobrazeno 21 - 30
of 50
pro vyhledávání: '"Ginde, Adit A."'
Autor:
Lauring, Adam S., Tenforde, Mark W., Chappell, James D., Gaglani, Manjusha, Ginde, Adit A., McNeal, Tresa, Ghamande, Shekhar, Douin, David J., Talbot, H. Keipp, Casey, Jonathan D., Mohr, Nicholas M., Zepeski, Anne, Shapiro, Nathan I., Gibbs, Kevin W., Files, D. Clark, Hager, David N., Shehu, Arber, Prekker, Matthew E., Erickson, Heidi L., Exline, Matthew C., Gong, Michelle N., Mohamed, Amira, Johnson, Nicholas J., Srinivasan, Vasisht, Steingrub, Jay S., Peltan, Ithan D., Brown, Samuel M., Martin, Emily T., Monto, Arnold S., Khan, Akram, Hough, Catherine L., Busse, Laurence W., ten Lohuis, Caitlin C., Duggal, Abhijit, Wilson, Jennifer G., Gordon, Alexandra June, Qadir, Nida, Chang, Steven Y., Mallow, Christopher, Rivas, Carolina, Babcock, Hilary M., Kwon, Jennie H., Halasa, Natasha, Grijalva, Carlos G., Rice, Todd W., Stubblefield, William B., Baughman, Adrienne, Womack, Kelsey N., Rhoads, Jillian P., Lindsell, Christopher J., Hart, Kimberly W., Zhu, Yuwei, Adams, Katherine, Schrag, Stephanie J., Olson, Samantha M., Kobayashi, Miwako, Verani, Jennifer R., Patel, Manish M., Self, Wesley H.
Publikováno v:
medRxiv
ObjectivesTo characterize the clinical severity of COVID-19 caused by Omicron, Delta, and Alpha SARS-CoV-2 variants among hospitalized adults and to compare the effectiveness of mRNA COVID-19 vaccines to prevent hospitalizations caused by each varian
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ebd4f623285c761ea8fed0b92062baf0
https://europepmc.org/articles/PMC8845432/
https://europepmc.org/articles/PMC8845432/
Autor:
Gottlieb, Robert L, Vaca, Carlos E, Paredes, Roger, Mera, Jorge, Webb, Brandon J, Perez, Gilberto, Oguchi, Godson, Ryan, Pablo, Nielsen, Bibi U, Brown, Michael, Hidalgo, Ausberto, Sachdeva, Yessica, Mittal, Shilpi, Osiyemi, Olayemi, Skarbinski, Jacek, Juneja, Kavita, Hyland, Robert H, Osinusi, Anu, Chen, Shuguang, Camus, Gregory, Abdelghany, Mazin, Davies, Santosh, Behenna-Renton, Nicole, Duff, Frank, Marty, Francisco M, Katz, Morgan J, Ginde, Adit A, Brown, Samuel M, Schiffer, Joshua T, Hill, Joshua A, Nielsen, Henrik
Publikováno v:
Gottlieb, R L, Vaca, C E, Paredes, R, Mera, J, Webb, B J, Perez, G, Oguchi, G, Ryan, P, Nielsen, B U, Brown, M, Hidalgo, A, Sachdeva, Y, Mittal, S, Osiyemi, O, Skarbinski, J, Juneja, K, Hyland, R H, Osinusi, A, Chen, S, Camus, G, Abdelghany, M, Davies, S, Behenna-Renton, N, Duff, F, Marty, F M, Katz, M J, Ginde, A A, Brown, S M, Schiffer, J T, Hill, J A, GS-US-540-9012 (PINETREE) Investigators & Nielsen, H 2022, ' Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients ', The New England Journal of Medicine, vol. 386, no. 4, pp. 305-315 . https://doi.org/10.1056/NEJMoa2116846
The New England Journal of Medicine
New England Journal of Medicine
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
The New England Journal of Medicine
New England Journal of Medicine
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Background Remdesivir improves clinical outcomes in patients hospitalized with moderate-to-severe coronavirus disease 2019 (Covid-19). Whether the use of remdesivir in symptomatic, nonhospitalized patients with Covid-19 who are at high risk for disea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9317030589eded6198a6dff29ba59a1
https://vbn.aau.dk/da/publications/65f84a60-59b0-4784-af13-20bb7af16518
https://vbn.aau.dk/da/publications/65f84a60-59b0-4784-af13-20bb7af16518
Autor:
Kaizer, Alexander M., Wild, Jessica, Lindsell, Christopher J., Rice, Todd W., Self, Wesley H., Brown, Samuel, Thompson, B. Taylor, Hart, Kimberly W., Smith, Clay, Pulia, Michael S., Shapiro, Nathan I., Ginde, Adit A.
Additional file 2. Statistical Analysis Plan.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1be0200d404f1fcc8421aeab6c7f9716
Autor:
Douin, David J., Wogu, Adane F., Beaty, Laurel E., Carlson, Nichole E., Bennett, Tellen D., Aggarwal, Neil R., Mayer, David A., Ong, Toan C., Russell, Seth, Steele, Jeffrey, Peers, Jennifer L., Molina, Kyle C., Wynia, Matthew K., Ginde, Adit A.
Additional file 5: Table S1. Medications and conditions used to stratify Mild versus Moderate/Severe immunocompromised status.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c34f97e91b2e89f17ab94be87585823
Autor:
Kaizer, Alexander M., Wild, Jessica, Lindsell, Christopher J., Rice, Todd W., Self, Wesley H., Brown, Samuel, Thompson, B. Taylor, Hart, Kimberly W., Smith, Clay, Pulia, Michael S., Shapiro, Nathan I., Ginde, Adit A.
Additional file 1. Study Protocol.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03b022382112ad58b6e201942313b134
Autor:
Tenforde, Mark W, Patel, Manish M, Gaglani, Manjusha, Ginde, Adit A, Douin, David J, Talbot, H Keipp, Casey, Jonathan D, Mohr, Nicholas M, Zepeski, Anne, McNeal, Tresa, Ghamande, Shekhar, Gibbs, Kevin W, Files, D Clark, Hager, David N, Shehu, Arber, Prekker, Matthew E, Erickson, Heidi L, Gong, Michelle N, Mohamed, Amira, Johnson, Nicholas J, Srinivasan, Vasisht, Steingrub, Jay S, Peltan, Ithan D, Brown, Samuel M, Martin, Emily T, Monto, Arnold S, Khan, Akram, Hough, Catherine L, Busse, Laurence W, Duggal, Abhijit, Wilson, Jennifer G, Qadir, Nida, Chang, Steven Y, Mallow, Christopher, Rivas, Carolina, Babcock, Hilary M, Kwon, Jennie H, Exline, Matthew C, Botros, Mena, Lauring, Adam S, Shapiro, Nathan I, Halasa, Natasha, Chappell, James D, Grijalva, Carlos G, Rice, Todd W, Jones, Ian D, Stubblefield, William B, Baughman, Adrienne, Womack, Kelsey N, Rhoads, Jillian P, Lindsell, Christopher J, Hart, Kimberly W, Zhu, Yuwei, Naioti, Eric A, Adams, Katherine, Lewis, Nathaniel M, Surie, Diya, McMorrow, Meredith L, Self, Wesley H, IVY Network
Publikováno v:
MMWR. Morbidity and mortality weekly report, vol 71, iss 4
COVID-19 mRNA vaccines (BNT162b2 [Pfizer-BioNTech] and mRNA-1273 [Moderna]) provide protection against infection with SARS-CoV-2, the virus that causes COVID-19, and are highly effective against COVID-19-associated hospitalization among eligible pers
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dfbf8d0a8ce9cddabb8808b7f2be779c
https://escholarship.org/uc/item/1sd607w7
https://escholarship.org/uc/item/1sd607w7
Autor:
Self, Wesley H, Tenforde, Mark W, Rhoads, Jillian P, Gaglani, Manjusha, Ginde, Adit A, Douin, David J, Olson, Samantha M, Talbot, H Keipp, Casey, Jonathan D, Mohr, Nicholas M, Zepeski, Anne, McNeal, Tresa, Ghamande, Shekhar, Gibbs, Kevin W, Files, D Clark, Hager, David N, Shehu, Arber, Prekker, Matthew E, Erickson, Heidi L, Gong, Michelle N, Mohamed, Amira, Henning, Daniel J, Steingrub, Jay S, Peltan, Ithan D, Brown, Samuel M, Martin, Emily T, Monto, Arnold S, Khan, Akram, Hough, Catherine L, Busse, Laurence W, Ten Lohuis, Caitlin C, Duggal, Abhijit, Wilson, Jennifer G, Gordon, Alexandra June, Qadir, Nida, Chang, Steven Y, Mallow, Christopher, Rivas, Carolina, Babcock, Hilary M, Kwon, Jennie H, Exline, Matthew C, Halasa, Natasha, Chappell, James D, Lauring, Adam S, Grijalva, Carlos G, Rice, Todd W, Jones, Ian D, Stubblefield, William B, Baughman, Adrienne, Womack, Kelsey N, Lindsell, Christopher J, Hart, Kimberly W, Zhu, Yuwei, Mills, Lisa, Lester, Sandra N, Stumpf, Megan M, Naioti, Eric A, Kobayashi, Miwako, Verani, Jennifer R, Thornburg, Natalie J, Patel, Manish M, IVY Network
Publikováno v:
MMWR. Morbidity and mortality weekly report, vol 70, iss 38
Three COVID-19 vaccines are authorized or approved for use among adults in the United States (1,2). Two 2-dose mRNA vaccines, mRNA-1273 from Moderna and BNT162b2 from Pfizer-BioNTech, received Emergency Use Authorization (EUA) by the Food and Drug Ad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______325::7c674ee56b06f117c6cba040dd60d78a
https://escholarship.org/uc/item/4197n7w3
https://escholarship.org/uc/item/4197n7w3
Autor:
Tenforde, Mark W, Self, Wesley H, Naioti, Eric A, Ginde, Adit A, Douin, David J, Olson, Samantha M, Talbot, H Keipp, Casey, Jonathan D, Mohr, Nicholas M, Zepeski, Anne, Gaglani, Manjusha, McNeal, Tresa, Ghamande, Shekhar, Shapiro, Nathan I, Gibbs, Kevin W, Files, D Clark, Hager, David N, Shehu, Arber, Prekker, Matthew E, Erickson, Heidi L, Gong, Michelle N, Mohamed, Amira, Henning, Daniel J, Steingrub, Jay S, Peltan, Ithan D, Brown, Samuel M, Martin, Emily T, Monto, Arnold S, Khan, Akram, Hough, Catherine L, Busse, Laurence W, Ten Lohuis, Caitlin C, Duggal, Abhijit, Wilson, Jennifer G, Gordon, Alexandra June, Qadir, Nida, Chang, Steven Y, Mallow, Christopher, Rivas, Carolina, Babcock, Hilary M, Kwon, Jennie H, Exline, Matthew C, Halasa, Natasha, Chappell, James D, Lauring, Adam S, Grijalva, Carlos G, Rice, Todd W, Jones, Ian D, Stubblefield, William B, Baughman, Adrienne, Womack, Kelsey N, Lindsell, Christopher J, Hart, Kimberly W, Zhu, Yuwei, Stephenson, Meagan, Schrag, Stephanie J, Kobayashi, Miwako, Verani, Jennifer R, Patel, Manish M, IVY Network Investigators, IVY Network
Publikováno v:
MMWR. Morbidity and mortality weekly report, vol 70, iss 34
Real-world evaluations have demonstrated high effectiveness of vaccines against COVID-19-associated hospitalizations (1-4) measured shortly after vaccination; longer follow-up is needed to assess durability of protection. In an evaluation at 21 hospi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______325::ddac6732121bb1d2e90ee21aaaac5d75
https://escholarship.org/uc/item/584662bk
https://escholarship.org/uc/item/584662bk
Autor:
Tenforde, Mark W, Olson, Samantha M, Self, Wesley H, Talbot, H Keipp, Lindsell, Christopher J, Steingrub, Jay S, Shapiro, Nathan I, Ginde, Adit A, Douin, David J, Prekker, Matthew E, Brown, Samuel M, Peltan, Ithan D, Gong, Michelle N, Mohamed, Amira, Khan, Akram, Exline, Matthew C, Files, D Clark, Gibbs, Kevin W, Stubblefield, William B, Casey, Jonathan D, Rice, Todd W, Grijalva, Carlos G, Hager, David N, Shehu, Arber, Qadir, Nida, Chang, Steven Y, Wilson, Jennifer G, Gaglani, Manjusha, Murthy, Kempapura, Calhoun, Nicole, Monto, Arnold S, Martin, Emily T, Malani, Anurag, Zimmerman, Richard K, Silveira, Fernanda P, Middleton, Donald B, Zhu, Yuwei, Wyatt, Dayna, Stephenson, Meagan, Baughman, Adrienne, Womack, Kelsey N, Hart, Kimberly W, Kobayashi, Miwako, Verani, Jennifer R, Patel, Manish M, IVY Network, HAIVEN Investigators
Publikováno v:
MMWR. Morbidity and mortality weekly report, vol 70, iss 18
Adults aged ≥65 years are at increased risk for severe outcomes from COVID-19 and were identified as a priority group to receive the first COVID-19 vaccines approved for use under an Emergency Use Authorization (EUA) in the United States (1-3). In
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______325::178fc3db4475c045a2f59f625d61ef7b
https://escholarship.org/uc/item/25n115bq
https://escholarship.org/uc/item/25n115bq
Autor:
Sami, Samira, Tenforde, Mark W, Talbot, H Keipp, Lindsell, Christopher J, Steingrub, Jay S, Shapiro, Nathan I, Ginde, Adit A, Douin, David J, Prekker, Matthew E, Erickson, Heidi L, Brown, Samuel M, Peltan, Ithan D, Gong, Michelle N, Khan, Akram, Exline, Matthew C, Files, D Clark, Gibbs, Kevin W, Rice, Todd W, Casey, Jonathan D, Grijalva, Carlos G, Stubblefield, William B, Womack, Kelsey N, Hager, David N, Qadir, Nida, Chang, Steven Y, Henning, Daniel J, Wilson, Jennifer G, Self, Wesley H, Patel, Manish M
Publikováno v:
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Because of the increased risk for severe coronavirus disease 2019 (COVID-19), the Advisory Committee on Immunization Practices (ACIP) initially prioritized COVID-19 vaccination for persons in long-term care facilities (LTCF), persons aged ≥65 years